• Tel. 900 101 549
  • +34 93 546 01 35
  • Facebook IOR
  • Twitter IOR
  • LinkedIn IOR
  • Hospital Universitari Dexeus
  • Centro Médico Teknon
  • Hospital Universitari General de Cataluña
  • Hospital Universitari Sagrat Cor

SCIENTIFIC PUBLICATIONS

Our medical oncologists and laboratory investigators are at the forefront of investigations into the causes of cancer and the search for novel treatments.

We have published the results of our investigations, often in collaboration with some of the most prestigious international institutions, in renowned medical journals such as the New England Journal of Medicine, Clinical Cancer Research, and many others.

CONSULT OUR SCIENTIFIC PUBLICATIONS

05/05/2017

Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens

AUTHORS Malapelle U, Mayo-de-Las-Casas C, Molina-Vila MA, Rosell R, Savic S, et al.

PUBLICATION Cancer. 2017 May 5. [Epub ahead of print]

READ ARTICLE

04/05/2017

Activation of signal transducer and activator of transcription 3 (STAT3) signaling in EGFR mutant non-small-cell lung cancer (NSCLC)

AUTHORS Codony-Servat C, Codony-Servat J, Karachaliou N, Molina MA, Chaib I, Ramirez JL, de Los Llanos Gil M, Solca F, Bivona TG, Rosell R.

PUBLICATION Oncotarget. 2017 May 4. [Epub ahead of print]

READ ARTICLE

03/05/2017

Ceritinib and cabozantinib: new tyrosine kinase inhibitors improve treatment options for non-small cell lung cancer patients

AUTHORS Viteri S, Rosell R

PUBLICATION Translational Cancer Research Vol 6, Supplement 3 (May 2017)

READ ARTICLE

01/05/2017

Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry

AUTHORS Gautschi O et al.

PUBLICATION Journal of Clinical Oncology 35, no. 13 (May 2017) 1403-1410.

READ ARTICLE

10/04/2017

Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial

AUTHORS Rosell R, Dafni U, Felip E et al.

PUBLICATION The Lancet Respiratory Medicine

LABELS NSCLC Clinical trials

READ ARTICLE